REFERENCES
- Sah R. L., Doong J. Y., Grodzinsky A. J., Plaas A. H., Sandy J. D.. 1991. Effects of compression on the loss of newly synthesized proteoglycans and proteins from cartilage explants. Arch. Biochem. Biophys.. 286: 20–29. [PUBMED], [INFOTRIEVE]
- Pelletier J. P., Roughley P. J., DiBattista J. A., McCollum R., Martel-Pelletier J.. 1991. Are cytokines involved in osteoarthritic pathophysiology?. Semin. Arthritis Rheum.. 20(suppl 2)12–25. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Knowlton R. G., Katzenstein P. L., Moskowitz R. W., Weaver E. J., Malemud C. J., Pathria M. N., Jimenez S. A., Prockop D. J.. 1990. Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N. Engl. J. Med.. 322: 526–530. [PUBMED], [INFOTRIEVE]
- Martel-Pelletier J., Pelletier J. P., Cloutier J. M., Howell D. S., Ghandur-Mnaymneh L., Woessner J. F., Jr.. 1984. Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum.. 27: 305–312. [PUBMED], [INFOTRIEVE]
- Goldring M. B.. 1999. The role of cytokines as inflammatory mediators in osteoarthritis: Lessons from animal models. Connect. Tissue Res.. 40: 1–11. [PUBMED], [INFOTRIEVE]
- Sun H. B., Nalim R., Yokota H.. 2003. Expression and activities of matrix metalloproteinases under oscillatory shear in IL-1-stimulated synovial cells. Connect. Tissue Res.. 44: 42–49. [PUBMED], [INFOTRIEVE]
- Joosten L. A., Helsen M. M., Saxne T., van De, Loo F. A., Heinegard D., van Den, Berg W. B.. 1999. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J. Immunol.. 163: 5049–5055. [PUBMED], [INFOTRIEVE]
- Martel-Pelletier J., Zafarullah M., Kodama S., Pelletier J. P.. 1991. In vitro effects of interleukin 1 on the synthesis of metalloproteinases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J. Rheumatol.. 18(Suppl)80–84
- Goldring M. B., Birkhead J. R., Suen L. F., Yamin R., Mizuno S., Glowacki J., Arbiser J. L., Apperley J. F.. 1994. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest.. 94: 2307–2316. [PUBMED], [INFOTRIEVE]
- Aydelotte M. B., Raiss R. X., Caterson B., Kuettner K. E.. 1992. Influence of interleukin-1 on the morphology and proteoglycan metabolism of cultured bovine articular chondrocytes. Connect. Tissue Res.. 28: 143–159. [PUBMED], [INFOTRIEVE]
- Jennings L., Wu L., King K. B., Hammerle H., Cs-Szabo G., Mollenhauer J.. 2001. The effects of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes. Connect. Tissue Res.. 42: 71–86. [PUBMED], [INFOTRIEVE]
- Mehraban F., Kasturi S.. 1998. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction. Arthritis Rheum.. 41: 515–524. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Oligino T., Ghivizzani S., Wolfe D., Lechman E., Krisky D., Mi Z., Evans C., Robbins P., Glorioso J.. 1999. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther.. 6: 1713–1720. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Neidhart M., Gay R. E., Gay S.. 2000. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum.. 43: 1719–1728. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- van den, Berg W. B.. 2000. Arguments for interleukin 1 as a target in chronic arthritis. Ann. Rheum. Dis.. 59(Suppl)181–184
- Birkedal-Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., Engler J. A.. 1993. Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med.. 4: 197–250. [PUBMED], [INFOTRIEVE]
- Gum R., Wang H., Lengyel E., Juarez J., Boyd D.. 1997. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene. 14: 1481–1493. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Cuzner M. L., Opdenakker G.. 1999. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol.. 94: 1–14. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Simon C., Goepfert H., Boyd D.. 1998. Inhibition of the p38 mitogen activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res.. 58: 1135–1139. [PUBMED], [INFOTRIEVE]
- Johnson M. D., Torri J. A., Lippman M. E., Dickson R. B.. 1999. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res.. 247: 105–113. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- McCawley L. J., Li S., Wattenberg E. V., Hudson L. G.. 1999. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem.. 274: 4347–4353. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Koolwijk P., Miltenburg A. M., van, Erck M. G., Oudshoorn M., Niedbala M. J., Breedveld F. C., van, Hinsbergh V. W.. 1995. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J. Rheumatol.. 22: 385–393. [PUBMED], [INFOTRIEVE]
- Lu K. H., Yang S. F., Chu S. C., Chen P. N., Chou M. C., Hsiao T. Y., Hsieh Y. S.. 2004. The significance of altered expressions of gelatinases in the synovium of patient with arthritic effusions. Clin. Rheumatol.. 23: 21–26. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Chu S. C., Yang S. F., Lue K. H., Hsieh Y. S., Hsiao T. Y., Lu K. H.. 2004. The clinical significance of gelatinase B in gouty arthritis of the knee. Clin. Chim. Acta. 339: 77–83. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Masuhara K., Bak, Lee S., Nakai T., Sugano N., Ochi T., Sasaguri Y.. 2000. Matrix metalloproteinases in patients with osteoarthritis of the hip. Intl. Orthop.. 24: 92–96. [CROSSREF], [CROSSREF]
- Maiotti M., Monteleone G., Tarantino U., Fasciglione G. F., Marini S., Coletta M.. 2000. Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy. 16: 522–526. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Nebelung W., Pap G., Machner A., Eberhardt R., Neumann H. W., Roessner A.. 2001. Evaluation of arthroscopic articular cartilage biopsy for osteoarthritis of the knee. Arthroscopy. 17: 286–289. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Hsieh Y. S., Yang S. F., Chu S. C., Chen P. N., Chou M. C., Hsu M. C., Lu K. H.. 2004. Expression changes of gelatinases in human osteoarthritic knee and arthroscopic débridement. Arthroscopy. 20: 482–488. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Sunic D., McNeil J. D., Andress D. L., Belford D. A.. 1998. Insulin-like growth factor binding protein-5 proteolytic activity in ovine articular chondrocyte culture. Biochim. Biophys. Acta. 1425: 567–576. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Lafleur M. A., Handsley M. M., Knauper V., Murphy G., Edwards D. R.. 2002. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci.. 115: 3427–3438. [PUBMED], [INFOTRIEVE]
- Mehraban F., Tindal M. H., Proffitt M. M., Moskowitz R. W.. 1997. Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: Gene expression in chondrocytes in response to interleukin-1 and matrix depletion. Ann. Rheum. Dis.. 56: 108–115. [PUBMED], [INFOTRIEVE]
- Johansen J. S., Olee T., Price P. A., Hashimoto S., Ochs R. L., Lotz M.. 2001. Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum.. 44: 826–837. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Chang Y. C., Yang S. F., Lai C. C., Liu J. Y., Hsieh Y. S.. 2002. Regulation of matrix metalloproteinases production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J. Periodont. Res.. 37: 196–203. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Rosado E., Schwartz Z., Sylvia V. L., Dean D. D., Boyan B. D.. 2002. Transforming growth factor-betal regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Biochim. Biophys. Acta. 1590: 1–15. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Tanaka S., Takasu Y., Mikura S., Satoh N., Ichikawa A.. 2002. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J. Exp. Med.. 196: 229–235. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Wu Y., Kumar R.. 2000. Parathyroid hormone regulates transforming growth factor betal and beta2 synthesis in osteoblasts via divergent signaling pathways. J. Bone Miner. Res.. 15: 879–884. [PUBMED], [INFOTRIEVE]
- Altman R. D.. 1991. Criteria for classification of clinical osteoarthritis. J. Rheum. Suppl.. 27: 10–12
- Kellgren J. H., Lawrence J. S.. 1957. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis.. 16: 494–502. [PUBMED], [INFOTRIEVE]
- Goldring M. B.. 2000. The role of the chondrocyte in osteoarthritis. Arthritis Rheum.. 43: 1916–1926. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Malemud C. J., Islam N., Haqqi T. M.. 2003. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs. 174: 34–48. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Lefebvre V., Peeters-Joris C., Vaes G.. 1991. Production of gelatin-degrading matrix metalloproteinases (type IV collagenases) and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor-a. Biochim. Biophys. Acta. 1094: 8–18. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Tetlow L. C., Adlam D. J., Woolley D. E.. 2001. Matrix metalloproteinases and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage. Association with degenerative changes. Arthritis Rheum.. 44: 585–594. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Rietschel E. T., Brade H., Holst O., Brade L., Muller-Loennies S., Mamat U., Zahringer U., Beckmann F., Seydel U., Brandenburg K., Ulmer A. J., Mattern T., Heine H., Schletter J., Loppnow H., Schonbeck U., Flad H. D., Hauschildt S., Schade U. F., Di, Padova F., Kusumoto S., Schumann R. R.. 1996. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol.. 216: 39–81. [PUBMED], [INFOTRIEVE]
- Chu S. C., Yang S. F., Lue K. H., Hsieh Y. S., Lin Z. I., Lu K. H.. 2004. Clinical significance of gelatinases in septic arthritis of the native and replaced knee. Clin. Orthop, (in press).
- Zhang F. X., Kirschning C. J., Mancinelli R., Xu X. P., Jin Y., Faure E., Mantovani A., Rothe M., Muzio M., Arditi M.. 1999. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem.. 274: 7611–7614. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., Mignatti P.. 1997. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J.. 16: 2319–2332. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Ramos-DeSimone N., Hahn-Dantona E., Sipley J., Nagase H., French D. L., Quigley J. P.. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem.. 274: 13066–13076. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Onodera S., Kaneda K., Mizue Y., Koyama Y., Fujinaga M., Nishihira J.. 2000. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J. Biol. Chem.. 275: 444–450. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Wertz I. E., Hanley M. R.. 1996. Diverse molecular provocation of programmed cell death. Trends Biochem. Sci.. 21: 359–364. [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Mautino G., Oliver N., Chanez P., Bousquet J., Capony F.. 1997. Increased release of matrix metalloproteinases-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am. J. Respir. Cell Mol. Biol.. 17: 583–591. [PUBMED], [INFOTRIEVE]
- Su S., DiBattista J. A., Sun Y., Li W. Q., Zafarullah M.. 1998. Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-β in articular chondrocytes is mediated by serine/threonine and tyrosine kinases. J. Cell. Biochem.. 70: 517–527. [PUBMED], [INFOTRIEVE]